NEWS

Takeover bid for ResApp final says determined Pfizer

MELBOURNE: Pfizer has told ASX-listed ResApp it will not increase its 20.8c per ... read more

Opthea locks in $239m for eye disease drug trials

MELBOURNE: Opthea has landed one of the biggest biotech raisings of the year, ... read more

ICG now set to hire Lazard for Healius pursuit

MELBOURNE: Intermediate Capital is understood to have hired advisory firm Lazard in its ... read more

Fisher & Paykel Healthcare expects sharp first half profit fall

AUCKLAND: Fisher & Paykel Healthcare’s share price dropped after the company said its ... read more